Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Taming killer cells may halt diabetes progression

Nature Immunology volume 11, pages 111–112 (2010)Cite this article

Subjects

Preclinical studies in mice suggest that the natural killer cell receptor NKp46 may be a new molecular target for delaying the progression of type 1 diabetes by interfering with unexpected natural killer cell–mediated recognition of pancreatic beta cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Targeting NKp46 to prevent diabetes.

Katie Vicari

References

  1. Flodstrom-Tullberg, M., Bryceson, Y.T., Shi, F.D., Hoglund, P. & Ljunggren, H.G. Curr. Opin. Immunol. 21, 634–640 (2009).

    Article  Google Scholar 

  2. Rodacki, M., Milech, A. & de Oliveira, J.E. Clin. Dev. Immunol. 13, 101–107 (2006).

    Article  CAS  Google Scholar 

  3. Gur, C. et al. Nat. Immunol. 11, 121–128 (2010).

    Article  CAS  Google Scholar 

  4. Biassoni, R. et al. Immunol. Rev. 181, 203–214 (2001).

    Article  CAS  Google Scholar 

  5. Halfteck, G.G. et al. J. Immunol. 182, 2221–2230 (2009).

    Article  CAS  Google Scholar 

  6. Lakshmikanth, T. et al. J. Clin. Invest. 119, 1251–1263 (2009).

    Article  CAS  Google Scholar 

  7. Gazit, R. et al. Nat. Immunol. 7, 517–523 (2006).

    Article  CAS  Google Scholar 

  8. Ogasawara, K. et al. Immunity 20, 757–767 (2004).

    Article  CAS  Google Scholar 

  9. Paik, S.G., Fleischer, N. & Shin, S.I. Proc. Natl. Acad. Sci. USA 77, 6129–6133 (1980).

    Article  CAS  Google Scholar 

  10. Richer, M.J. & Horwitz, M.S. Autoimmun. Rev. 8, 611–615 (2009).

    Article  CAS  Google Scholar 

  11. Colonna, M. Immunity 31, 15–23 (2009).

    Article  CAS  Google Scholar 

  12. Vivier, E., Spits, H. & Cupedo, T. Nat. Rev. Immunol. 9, 229–234 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Francesco Colucci is in the Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge and Centre for Trophoblast Research, University of Cambridge, Cambridge, UK.,

    Francesco Colucci

  2. Department of Clinical Sciences, Corrado M. Cilio is in the Cellular Autoimmunity Unit, Lund University, Lund, Sweden.,

    Corrado M Cilio

Authors
  1. Francesco Colucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Corrado M Cilio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Colucci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Colucci, F., Cilio, C. Taming killer cells may halt diabetes progression. Nat Immunol 11, 111–112 (2010). https://doi.org/10.1038/ni0210-111

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni0210-111

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing